Lataa...
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin‐induced cachexia
BACKGROUND: Cachexia is a wasting condition associated with cancer types and, at the same time, is a serious and dose‐limiting side effect of cancer chemotherapy. Skeletal muscle loss is one of the main characteristics of cachexia that significantly contributes to the functional muscle impairment. C...
Tallennettuna:
| Julkaisussa: | J Cachexia Sarcopenia Muscle |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703021/ https://ncbi.nlm.nih.gov/pubmed/28294567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12185 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|